Viridian Therapeutics Inc (VRDN) Insider Trading
- $20,261,773.50
- $6,517,369.80
- Jan. 22, 2024
- Lara Meisner
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 22, 2024 | Director | 476,190 | $21.00 | Buy | $9,999,990.00 | |
| June 15, 2023 | Insider | 2,269 | $28.02 | Sell | $63,577.38 | |
| June 5, 2023 | Insider | 499 | $25.03 | Sell | $12,489.97 | |
| June 2, 2023 | Insider | 1,875 | $24.21 | Sell | $45,393.75 | |
| April 12, 2023 | CEO | 4,000 | $25.37 | Buy | $101,480.00 | |
| March 13, 2023 | CEO | 5,500 | $29.15 | Buy | $160,325.00 | |
| March 9, 2023 | General Counsel | 29,971 | $29.07 | Sell | $871,256.97 | |
| Feb. 2, 2023 | Insider | 50,000 | $36.80 | Sell | $1,840,000.00 | |
| Jan. 23, 2023 | General Counsel | 6,843 | $35.66 | Sell | $244,021.38 | |
| Jan. 17, 2023 | insider | 24,853 | $37.21 | Sell | $924,780.13 | |
| Jan. 13, 2023 | insider | 4,147 | $37.01 | Sell | $153,480.47 | |
| Jan. 10, 2023 | insider | 47,377 | $35.30 | Sell | $1,672,408.10 | |
| Dec. 20, 2022 | General Counsel | 600 | $28.07 | Sell | $16,842.00 | |
| Dec. 16, 2022 | General Counsel | 1,297 | $28.44 | Sell | $36,886.68 | |
| Dec. 14, 2022 | General Counsel | 15,656 | $28.12 | Sell | $440,246.72 | |
| Dec. 12, 2022 | General Counsel | 600 | $28.05 | Sell | $16,830.00 | |
| Nov. 15, 2022 | General Counsel | 8,125 | $22.05 | Sell | $179,156.25 | |
| Aug. 17, 2022 | Director | 425,531 | $23.50 | Buy | $9,999,978.50 |
Insiders are both buying and selling Viridian Therapeutics Inc stock.
The insider traders at Viridian Therapeutics Inc are: Lara Meisner, Barrett Katz, Fairmount Funds Management Llc, Scott Dunseth Myers, and Jonathan Violin
The most active insider trader at Viridian Therapeutics Inc is Lara Meisner with 10 trades.
Jonathan Violin has sold the most Viridian Therapeutics Inc stock with a total value of $3,680,000.00.
Fairmount Funds Management Llc has bought the most Viridian Therapeutics Inc stock with a total value of $29,999,958.50.
The most recent insider trade for Viridian Therapeutics Inc was on Jan. 22, 2024.
The single biggest insider buy for Viridian Therapeutics Inc was from Fairmount Funds Management Llc with a total value of $9,999,990.00 on Jan. 22, 2024.
The single biggest insider sell for Viridian Therapeutics Inc was from Jonathan Violin with a total value of $1,840,000.00 on Feb. 2, 2023.